SAN FRANCISCO, July 19, 2011 /PRNewswire/ — ClinStar, LLC, an
established CRO providing clinical research services in the
emerging markets of Russia and Eastern Europe to the pharmaceutical
and biotechnology industry, announced today the opening of a new
regional office on the East Coast of the United States.
(Photo: http://photos.prnewswire.com/prnh/20110719/SF36975LOGO)
As a second US location to its headquarters in San Francisco,
CA, ClinStar’s new office is located at 1000 Park Forty Plaza,
Durham, NC. In addition to offering adequate space to centralize
ClinStar’s regional workforce, the new facility was chosen in large
part because of its flexibility to accommodate the company’s future
growth.
According to President and CEO David Passov, “This is the
realization of a major long-term business goal for ClinStar. Our
new office further solidifies our commitment to offer our clients
the local expertise and knowledge they need to successfully conduct
clinical trials in Russia and Eastern Europe while ensuring our
business operates in accordance with the proven business and
management principles practiced in the West.”
“We are thrilled with the opening of our new office,” says Erin
King, Executive Director Business Development and Marketing. This
move is just one of several important initiatives positioning
ClinStar as the leading provider of clinical research services in
Russia, Ukraine and parts of Eastern Europe. Our new facility
affords not only centralized office space for our employees, but
also upscale conference space for hosting meetings with our
customers.”
About ClinStar, LLC
ClinStar is one of the most prominent CROs in the emerging
markets of Eastern Europe and the Baltics, with more than 10 years
of expertise in Phase I-IV clinical studies in multiple therapeutic
areas. Headquartered in San Francisco, California, Clin
‘/>”/>
SOURCE